News & Events

C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing

RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON, Ariz. and ALISO VIEJO, Calif., September 13, 2021 — Critical Path Institute (C-Path), who’s aim is to catalyze the development of new approaches that advance medical innovation and regulatory science, today announced a collaboration with […]

Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field

Tuesday, September 14,the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), an FDA-funded initiative, will have its public premiere during the annual meeting for the project. The platform will host, standardize and share rare diseases data as part of its functionality.

C-Path Appoints Clinical Outcome Assessment Expert as New Executive Director

Sonya Eremenco will lead C-Path’s PRO Consortium TUCSON, Ariz., August 5, 2021— Critical Path Institute (C-Path) announced it has named Sonya Eremenco, M.A., as Executive Director of its Patient-Reported Outcome (PRO) Consortium. Eremenco joined C-Path in 2016 as Associate Director of the PRO Consortium and was promoted to Director in January 2021. In addition to […]

Digital Health Technologies Hold Key to New Parkinson’s Treatments

Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies. TUCSON, Ariz., July 20, 2021 — The use of digital health technologies across health care and drug development has accelerated. A new paper titled “Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective,” co-authored by experts across […]